Latest Ratios: P/E Ratio -0.0x · EV/EBITDA N/A · ROE N/A. (2020–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Market Cap | $999334 | $6M | $53M | $161M | — | — | — |
| Enterprise Value | $45M | $50M | $98M | $196M | — | — | — |
| P/E Ratio → | -0.01 | — | — | — | — | — | — |
| P/S Ratio | 0.08 | 0.46 | 0.75 | 2.72 | — | — | — |
| P/B Ratio | — | — | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4.06 | 1.39 | 3.32 | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 44.4% | 44.4% | 68.3% | 66.6% | 63.9% | 66.5% | 47.8% |
| Operating Margin | -783.6% | -783.6% | -18.3% | -37.1% | -6.5% | 15.4% | -56.8% |
| Net Profit Margin | -821.1% | -821.1% | -20.6% | -44.7% | -12.2% | 11.3% | -49.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | — |
| ROA | -199.6% | -199.6% | -19.1% | -41.7% | -10.9% | 10.2% | -27.0% |
| ROIC | — | — | -34.4% | -55.3% | -8.0% | 19.6% | -50.0% |
| ROCE | — | — | -339.6% | -263.4% | -32.8% | 94.8% | — |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — | 4.97 | — |
| Net Debt / Equity | — | — | — | — | — | — | — |
| Net Debt / EBITDA | — | — | — | — | — | 4.76 | — |
| Debt / FCF | — | — | — | — | — | — | — |
| Interest Coverage | -32.11 | -32.11 | -5.27 | -8.99 | -1.19 | 3.10 | -5.91 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.10 | 0.10 | 0.88 | 0.66 | 0.92 | 0.99 | 0.47 |
| Quick Ratio | 0.10 | 0.10 | 0.88 | 0.64 | 0.91 | 0.97 | 0.46 |
| Cash Ratio | 0.02 | 0.02 | 0.01 | 0.03 | 0.02 | 0.04 | 0.03 |
| Asset Turnover | — | 0.78 | 0.82 | 0.89 | 0.80 | 0.69 | 0.55 |
| Inventory Turnover | — | — | 1550.26 | 16.22 | 22.62 | 14.16 | 26.44 |
| Days Sales Outstanding | — | 121.06 | 349.98 | 189.60 | 318.67 | 355.45 | 212.11 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $691774 | $457855 | $394099 | $368593 | $372709 | $368593 |
Imminent insolvency and dilution
As reported in recent financial filings, AIXI's price-to-sales ratio of 0.09 suggests that the market has heavily discounted the company's equity, likely pricing in the extreme risk of insolvency rather than any potential upside from its intellectual property portfolio or future government-led AI contract wins.
The current valuation multiple appears to reflect a market consensus that the company's historical revenue base is no longer a reliable indicator of future performance. Investors should monitor whether this deep discount represents a genuine value opportunity or a rational response to the company's inability to generate positive earnings or cash flow.
Based on the company's reported figures, the return on invested capital has deteriorated from a peak of 60.3% in 2021Q4 to deeply negative levels, indicating that the firm is currently destroying shareholder value rather than compounding it through its specialized cognitive intelligence platform investments.
The sharp decline in ROIC suggests that the company's heavy R&D spending is failing to translate into profitable growth or sustainable competitive advantages. This trend warrants further investigation into whether the firm's core technology remains relevant in a rapidly evolving AI landscape or if the capital structure is simply too impaired to support further innovation.
According to the latest quarterly data, the company's days sales outstanding reached an alarming 3,888 days in 2025Q4, which implies that the firm is struggling significantly to collect payments from its government and enterprise clients, thereby severely constraining its internal liquidity and operational flexibility.
The extreme duration of the collection cycle suggests that the company's revenue recognition may be significantly decoupled from actual cash receipts. This inefficiency appears to be a structural issue inherent in the firm's B2G project-based model, which leaves the business highly vulnerable to municipal budget cycles and payment delays.
As indicated by the provided balance sheet data, the current ratio has collapsed to a precarious 0.10, leaving the company with minimal liquid assets to cover its short-term obligations and suggesting that the firm may face an imminent liquidity crisis without immediate external capital support.
The lack of a sufficient liquidity buffer indicates that the company is operating with almost no margin for error in its cash management. Investors should monitor the company's ability to secure non-dilutive financing, as the current cash position appears insufficient to sustain ongoing operations under the existing cost structure.
Analysts frequently misapply the price-to-sales ratio to AIXI, failing to account for the fact that the company's revenue is largely derived from lumpy, project-based government contracts that do not reflect the recurring, high-margin nature of a true software-as-a-service business model.
Using P/S as a primary valuation tool obscures the underlying cash flow volatility and the high cost of implementation associated with the firm's bespoke AI solutions. A more appropriate metric would be an adjusted cash-burn-to-liquidity ratio, which better captures the immediate survival risks inherent in the company's current financial state.
Includes 30+ ratios · 6 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AIXI stock.
Xiao-I Corporation's current P/E ratio is -0.0x. This places it at the 50th percentile of its historical range.
Based on historical data, Xiao-I Corporation is trading at a P/E of -0.0x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Xiao-I Corporation has 44.4% gross margin and -783.6% operating margin.